209 related articles for article (PubMed ID: 30903933)
21. Prevalence and Risk Factors of HBV and HCV Co-Infection Among People Living with HIV in an Egyptian Setting.
El-Ghitany EM; Farghaly AG; Alkassabany YM
Curr HIV Res; 2021; 19(6):514-524. PubMed ID: 34353267
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.
Maponga TG; Glashoff RH; Vermeulen H; Robertson B; Burmeister S; Bernon M; Omoshoro-Jones J; Ruff P; Neugut AI; Jacobson JS; Preiser W; Andersson MI
BMC Gastroenterol; 2020 Jul; 20(1):226. PubMed ID: 32660431
[TBL] [Abstract][Full Text] [Related]
23. Contribution of hepatitis B virus and hepatitis C virus to liver cancer in China north areas: Experience of the Chinese National Cancer Center.
Wang M; Wang Y; Feng X; Wang R; Wang Y; Zeng H; Qi J; Zhao H; Li N; Cai J; Qu C
Int J Infect Dis; 2017 Dec; 65():15-21. PubMed ID: 28935244
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis B and C virus infection among HIV patients within the public and private healthcare systems in Chile: A cross-sectional serosurvey.
Weitzel T; Rodríguez F; Noriega LM; Marcotti A; Duran L; Palavecino C; Porte L; Aguilera X; Wolff M; Cortes CP
PLoS One; 2020; 15(1):e0227776. PubMed ID: 31917810
[TBL] [Abstract][Full Text] [Related]
25. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
26. The Hepatitis Viral Status in Patients With Hepatocellular Carcinoma: a Study of 3843 Patients From Taiwan Liver Cancer Network.
Chang IC; Huang SF; Chen PJ; Chen CL; Chen CL; Wu CC; Tsai CC; Lee PH; Chen MF; Lee CM; Yu HC; Lo GH; Yeh CT; Hong CC; Eng HL; Wang J; Tseng HH; Hsiao CH; Wu HI; Yen TC; Liaw YF
Medicine (Baltimore); 2016 Apr; 95(15):e3284. PubMed ID: 27082566
[TBL] [Abstract][Full Text] [Related]
27. Incidence of hepatocellular carcinoma in HIV/HBV-coinfected patients on tenofovir therapy: Relevance for screening strategies.
Wandeler G; Mauron E; Atkinson A; Dufour JF; Kraus D; Reiss P; Peters L; Dabis F; Fehr J; Bernasconi E; van der Valk M; Smit C; Gjærde LK; Rockstroh J; Neau D; Bonnet F; Rauch A;
J Hepatol; 2019 Aug; 71(2):274-280. PubMed ID: 30965070
[TBL] [Abstract][Full Text] [Related]
28. Viral hepatitis markers in liver tissue in relation to serostatus in hepatocellular carcinoma.
Hernandez BY; Zhu X; Kwee S; Chan OT; Tsai N; Okimoto G; Horio D; McGlynn KA; Altekruse S; Wong LL
Cancer Epidemiol Biomarkers Prev; 2013 Nov; 22(11):2016-23. PubMed ID: 23983238
[TBL] [Abstract][Full Text] [Related]
29. Does dual infection by hepatitis B and C viruses play an important role in the pathogenesis of hepatocellular carcinoma in Japan?
Shiratori Y; Shiina S; Zhang PY; Ohno E; Okudaira T; Payawal DA; Ono-Nita SK; Imamura M; Kato N; Omata M
Cancer; 1997 Dec; 80(11):2060-7. PubMed ID: 9392327
[TBL] [Abstract][Full Text] [Related]
30. Why is hepatocellular carcinoma less attributable to viral hepatitis in Yemen?
Saeed NM; Bawazir AA; Al-Zuraiqi M; Al-Negri F; Yunus F
Asian Pac J Cancer Prev; 2012; 13(8):3663-7. PubMed ID: 23098451
[TBL] [Abstract][Full Text] [Related]
31. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
32. Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis.
Chiaramonte M; Stroffolini T; Vian A; Stazi MA; Floreani A; Lorenzoni U; Lobello S; Farinati F; Naccarato R
Cancer; 1999 May; 85(10):2132-7. PubMed ID: 10326690
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma among US and non-US-born patients with chronic hepatitis B: Risk factors and age at diagnosis.
Kennedy K; Graham SM; Arora N; Shuhart MC; Kim HN
PLoS One; 2018; 13(9):e0204031. PubMed ID: 30252863
[TBL] [Abstract][Full Text] [Related]
34. Geographic characterization of hepatitis virus infections, genotyping of hepatitis B virus, and p53 mutation in hepatocellular carcinoma analyzed by in situ detection of viral genomes from carcinoma tissues: comparison among six different countries.
Ding X; Park YN; Taltavull TC; Thung SN; Jin X; Jin Y; Trung NS; Edamoto Y; Sata T; Abe K
Jpn J Infect Dis; 2003 Feb; 56(1):12-8. PubMed ID: 12711820
[TBL] [Abstract][Full Text] [Related]
35. Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.
Tagger A; Donato F; Ribero ML; Chiesa R; Portera G; Gelatti U; Albertini A; Fasola M; Boffetta P; Nardi G
Int J Cancer; 1999 May; 81(5):695-9. PubMed ID: 10328218
[TBL] [Abstract][Full Text] [Related]
36. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis.
Benvegnù L; Alberti A
Antiviral Res; 2001 Nov; 52(2):199-207. PubMed ID: 11672830
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
38. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus.
Tanaka H; Tsukuma H; Yamano H; Oshima A; Shibata H
Int J Cancer; 2004 Dec; 112(6):1075-80. PubMed ID: 15386355
[TBL] [Abstract][Full Text] [Related]
39. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
40. Human Immunodeficiency Virus/Hepatitis C Virus (HCV) Co-infected Patients With Cirrhosis Are No Longer at Higher Risk for Hepatocellular Carcinoma or End-Stage Liver Disease as Compared to HCV Mono-infected Patients.
Salmon-Ceron D; Nahon P; Layese R; Bourcier V; Sogni P; Bani-Sadr F; Audureau E; Merchadou L; Dabis F; Wittkop L; Roudot-Thoraval F;
Hepatology; 2019 Sep; 70(3):939-954. PubMed ID: 30569448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
